Eating disorders: a role for dipeptidyl peptidase IV in nutritional control (Q43635024)

25 November 2017

Eating disorders: a role for dipeptidyl peptidase IV in nutritional control (English)

1 reference

25 November 2017

0 references

1 reference

Hildebrandt M

1

1 reference

25 November 2017

Rose M

2

1 reference

25 November 2017

Mönnikes H

3

1 reference

25 November 2017

Reutter W

4

1 reference

25 November 2017

Keller W

5

1 reference

25 November 2017

Klapp BF

6

1 reference

25 November 2017

1 June 2001

1 reference

25 November 2017

1 reference

25 November 2017

17

1 reference

25 November 2017

6

1 reference

25 November 2017

451-454

1 reference

Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders.

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptide Y by vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Identification of the 110000 Mr glycoprotein isolated from rat liver plasma membrane as dipeptidylaminopeptidase IV

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Alterations in plasma dipeptidyl peptidase IV enzyme activity in depression and schizophrenia: effects of antidepressants and antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Decreased serum dipeptidyl peptidase IV activity in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Bone metabolism and osteopenia in eating disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme)

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Tissue-specific regulation of dipeptidyl peptidase IV expression during development

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Design of (omega-N-(O-acyl)hydroxy amid) aminodicarboxylic acid pyrrolidides as potent inhibitors of proline-specific peptidases.

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Nutrition and the immune system: an introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Characterization of the 4C8 antigen involved in transendothelial migration of CD26(hi) T cells after tight adhesion to human umbilical vein endothelial cell monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0899-9007%2801%2900547-0

7 January 2021

10.1016/S0899-9007(01)00547-0

Identifiers

DOI

1 reference

25 November 2017

1 reference